Original document(25 pages) Authorized document(24 pages) 中文版
    The present invention relates to a Petri dish for cultivating bacteria used for an isolation of the bacteria, an enrichment culture, a drug susceptibility test, etc. and the method of inspecting the drug susceptibility of the bacteria which are isolated from a clinical specimen etc. or purely cultured after their isolation, with the Petri dish being utilized. A mouth in the upper edge of the Petri dish proper is covered with at least one sheet and at least one small aperture is provided on the bottom of said Petri dish. If necessary, partitions the height of which reaches the distance between the bottom of the Petri dish and the sheet may be installed, and a sealing lid may be fitted in the small aperture. The method of the present invention, using the fractionized Petri dish possessing the pervious sheet as the cultivation surface, assorts the media different in kind from each other, the media being different in the kind of the contained drug from each other or the media containing the drugs which are same in kind, but different in the concentration from each other in each fraction, into which the bacteria are inoculated.
Application Number
申请号
85106361 Application Date
申请日
1985.08.24
Title 名称 Petri dish for cultivating bacteria and method of inspecting drug susceptibility
Publication Number
公开号
1000512 Publication Date
公开日
1986.04.10
Approval Pub. Date 1988.09.28 Granted Pub. Date 1988.09.28
International Classification 分类号 C12M1/22;C12Q1/02
Applicant(s) Name
申请人
Kobayashi Pharmaccutical Co. Ltd.
Address 地址
Inventor(s) Name 发明人 Kazuyuki Sugahara;Kenzi Asano;Tetsuya Takakura
Attorney & Agent 代理人 WU XIAONAN
More information 更  多  信  息


 Related patents information
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.